Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TAK-701 |
Synonyms | |
Therapy Description |
TAK-701 is a monoclonal antibody that targets HGF and prevents its binding to MET, resulting in decreased activation of HGF/MET signaling and potentially resulting in increased tumor cell death (PMID: 24019233). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TAK-701 | HuL2G7 | HGF Antibody 4 | TAK-701 is a monoclonal antibody that targets HGF and prevents its binding to MET, resulting in decreased activation of HGF/MET signaling and potentially resulting in increased tumor cell death (PMID: 24019233). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|